The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-7B Multiple Myeloma: Clinical Studies (2)

Sun. Oct 13, 2019 10:10 AM - 11:10 AM No.7 (Tokyo International Forum, 5F Hall D5)

Chair: Hirohiko Shibayama (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

[OS3-7B-4] The safety profile of daratumumab in Japanese patients with relapsed/refractory multiple myeloma

Yasuhiko Miyata1, Manami Takizawa1, Masayuki Takagishi2, Haruyoshi Kawai2, Akiko Fujino3, Tsutomu Yajima4, Eriko Arita5, Kentaro Enjo1 (1.Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan, 2.Safety Risk Management Division, Janssen Pharma K. K., 3.Japan Safety & Surveillance Division, Janssen Pharma K. K., 4.Biostatistics, Janssen Pharma K. K., 5.Quantitative Sciences Division, Janssen Pharma K. K.)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password